Fuxue Zhang

Fuxue Zhang

Auto-generated profile, based on publicly available information

Fuxue Zhang

Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, P. R. China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2025 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
YZYixin Zhong
Yixin Zhong
QNQiankun Ni
Qiankun Ni
LHLiandi Huang
Liandi Huang
GQGuangchao Qing
Guangchao Qing
FZFuxue Zhang
Fuxue Zhang
XLXingjie Liang
Xingjie Liang

24 December 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
GQGuangchao Qing
Guangchao Qing
YZYuxuan Zhang
Yuxuan Zhang
YWYongchao Wang
Yongchao Wang
XLXianlei Li
Xianlei Li
TLTing Luo
Ting Luo
YLYang Luo
Yang Luo
Sepsis-associated secondary infection often leads to a high mortality rate. Dysfunctional macrophages are primary contributors to inadequate antimicrobial defense in patients with sepsis-associated immunosuppression. Rejuvenating macrophage antibacterial capacity is beneficial for host defense against secondary infection. Here, we developed “BATMAN” (bacteria-targeted transformable macrophage nanorejuvenator), a self-assembling peptide nanoparticle to tackle sepsis-associated secondary infection by coordinating the arrest of invasive bacteria and rejuvenation of dysfunctional macrophages. BATMAN comprises a bacteria-targeting ubiquicidin peptide domain, bacterial lipase–sensitive cholesteryl hemisuccinate, an assembly-driving FFVLK domain, and the immunoglobulin G–derived tuftsin peptide. Upon activation by bacterial lipase, the particles undergo an inside-out transformation and assembly to expose and cluster the concealed tuftsin peptides for interaction with macrophage Fcγ receptors. Interaction of tuftsin clusters with macrophage Fcγ receptors enhanced bacterial phagocytosis and drove macrophage repolarization. In a cecal slurry–induced septic mouse model with secondary pulmonary infection, BATMAN treatment improved survival rates and rejuvenated the sepsis-compromised immune response to address polymicrobial- and multidrug-resistant pathogen–induced pulmonary infections. These findings suggest that BATMAN holds promise for further development as a therapeutic alternative for sepsis-associated secondary infection.